Cotización Ishares S&P ASX 20 - ILC | ADVFN

US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
ETFs
Australia
ASX
Ishares S&P ASX 20 (ILC) Cotización

Ishares S&P ASX 20 (ILC)

31.56

0.00

(0.00%)

Cerrado 14 Enero 11:00PM

Delayed by 20 minutes

Herramientas de nivel profesional para inversores individuales.

Último Precio

31.56

Postura de Compra

32.52

Postura de Venta

32.50

Volume Operado de la Acción

-

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

Precio Anterior

31.56

Precio de Apertura

-

Hora

Última hora de negociación

Volumen financiero

-

Precio Promedio Ponderado

-

Volumen promedio (3 m)

-

Acciones en circulación

-

Rendimiento del Dividendo

-

Ratio Precio/Utilidad

0.00

Beneficio por acción (BPA)

-

turnover

80.1M

Beneficio neto

78.69M

Sector

Mgmt Invt Offices, Open-end

Industria

Mgmt Invt Offices, Open-end

Sitio web

www.ishares.com.au

Sede

Sydney, New South Wales, Aus

Fundado

-

Ishares S&P ASX 20 is listed in the Mgmt Invt Offices, Open-end sector of the Australian Stock Exchange with ticker ILC. The last closing price for Ishares S&P ASX 20 was AUD31.56. Over the last year, Ishares S&P ASX 20 shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Ishares S&P ASX 20 currently has 0 shares in issue.

No news to show yet.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
HEESH and E Equipment Services Inc	US$ 90.2921 (105.49%)	12.21M
AIFFFirefly Neuroscience Inc	US$ 3.30 (73.68%)	126.59M
ERNAEterna Therapeutics Inc	US$ 0.518532 (67.81%)	557.19M
TDUPThredUp Inc	US$ 1.86 (43.08%)	12.91M
RGTIRigetti Computing Inc	US$ 8.5348 (41.07%)	310.77M
PHIOPhio Pharmaceuticals Corporation	US$ 3.47 (-47.42%)	10.48M
MBIOMustang Bio Inc	US$ 0.1425 (-36.36%)	14.28M
BNRGBrenmiller Energy Ltd	US$ 1.82 (-29.46%)	763.58k
AEHRAehr Test Systems	US$ 11.39 (-28.77%)	4.9M
ATPCAgape ATP Corporation	US$ 1.41 (-28.43%)	1.14M
ERNAEterna Therapeutics Inc	US$ 0.5154 (66.80%)	557.2M
RGTIRigetti Computing Inc	US$ 8.5101 (40.66%)	310.94M
NMHINatures Miracle Holding Inc	US$ 1.58 (39.82%)	162.21M
GCTKGlucoTrack Inc	US$ 0.1229 (-17.90%)	160.1M
NVDANVIDIA Corporation	US$ 130.55 (-2.01%)	157.71M

georgie18

georgie18 5 minutos hace

SGLY... $2.44...🥳

georgie18

Member Level
Re: georgie18 post# 126

Monday, January 13, 2025 4:09:22 PM

Post#
127
of 127
SGLY...$2.39...HOD...🥳...Tapping the Upper Band...

georgie18

georgie18

georgie18 5 minutos hace

SGLY... $2.44...🥳

georgie18

Member Level
Re: georgie18 post# 126

Monday, January 13, 2025 4:09:22 PM

Post#
127
of 127
SGLY...$2.39...HOD...🥳...Tapping the Upper Band...

georgie18

alertmeipp

alertmeipp 5 minutos hace

I hope the M&A specialists in big pharma are monitoring the RSV market dynamics as closely as you are.

It’s difficult to comprehend how a company with a leading program in such a significant indication is trading at a negative enterprise value.

Wonder if they will provi

tw0122

tw0122 5 minutos hace

XRTX $1.50s + 20% gout urine kidneys FDA

style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: -apple-system; font-size: 15px; text-align: justify"am with the US Food and Drug Administration (“FDA”) regarding preparation of a New Drug Application (“NDA”). Pending F

georgie18

georgie18 5 minutos hace

SGLY... $2.44...🥳

georgie18

Member Level
Re: georgie18 post# 126

Monday, January 13, 2025 4:09:22 PM

Post#
127
of 127
SGLY...$2.39...HOD...🥳...Tapping the Upper Band...

georgie18

ace65

ace65 5 minutos hace

OTCN has left the ask completely after all that dumping just now.
Teasing or finished.?

vein

vein 5 minutos hace

I may have to lighten up here . I thought the risk would be gone after approval

3331

3331 6 minutos hace

SILENCE! After hurling all those juvenile insults, none of you can come up with an answer? Put your heads together and try to come up with one. I know you can't! Again, don't mention DILUTION, which is a completely different matter.

johnnytrader33

johnnytrader33 6 minutos hace

NO BID COMING HAHAHAHAHAHAHHAAHHA Talk about completely destroying all shareholder value. I said this would happen and I was not wrong AGAIN.

quester614

quester614 7 minutos hace

Angle investor sounds so nice. That must make you feel really good inside while Duffy SCAMS naive retail investors that didn't get the F&F discount.

F14SVF24

F14SVF24 7 minutos hace

On level 2 HMBL, all of the top MM's are now at .001 ask.

dewophile

dewophile 7 minutos hace

usually presentations don't have much new information and just rehash what most investors already know, although JPM may be the exception
anyway no bounce, but enta seems to be down in line w the index as I type so nothing unusual to the downside either rn

BlazingStocks

BlazingStocks 7 minutos hace

$COEP - This transformative AI-powered tool is designed to empower marketers to process vast amounts of data, optimize campaigns, enhance customer engagement, and streamline operations—crucial elements in the highly regulated sectors of biotech, pharmaceutical, and multi-level marketing (MLM) indust

surfkast

surfkast 7 minutos hace

Good old Teffy and many others were OK years ago. They they got greedy and started screwing everyone! Even their own scammer pals. LOL
FWIW, I called some of the biggest runners years ago!

SRSR 11/8/07 http://investorshub.advfn.com/boards/read_msg.aspx?message_id=24194319

dexprs

dexprs 8 minutos hace

Sold: DASH, CRDO and FHN for gains.
Bought back NVDA 15 Puts for a 12% gain.

sumbuysumsell

sumbuysumsell 8 minutos hace

Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical

NeoSunTzu

NeoSunTzu 8 minutos hace

Nice! Oh, btw, the next time you chat tell KThomp to kiss my a$$. Our shares now have a nickel for just about every time he claimed they'd be a "nickel."

blackhawks

blackhawks 8 minutos hace

AI Perplexity response to.....an effort to get these fire suppression systems on the fires when they are just beginning and small -- in the LA fires they apparently were not fully employed until after several days. Is that accurate?

Key words: extreme weather conditions and, especia

Slojab

Slojab 8 minutos hace

You wonder about the most meaningless things.

Maybe it wasn't mentioned because Assentato had nothing to do with TWOH being either one. That was all Elutiv's doing. All Assentato has been able to accomplish here is to muck things up. All his highly touted experience doesn't seem to h

Clark6290

Clark6290 8 minutos hace

No, still here Amigo. Those dang MM manipulators caused the pps spike. Now the twins have all sorts of gaps.

Prudent Capitalist

Prudent Capitalist 8 minutos hace

The pace of GameStop's store closures is rapidly accelerating, with a number of articles out in local papers in the last week of the closure of a number of stores in New York, the "Capital Region" and Suburban Detroit. Looks like another 150 stores closing across the US, on top of the 300 stores cl

georgejjl

georgejjl 8 minutos hace

https://www.youtube.com/watch?v=LyP7gsp2g8w

nonfiction video

Good luck and GOD bless,

Smartypants2

Smartypants2 8 minutos hace

XERIANT isn't the inventor. Inventors are people (ie, "Scott Duffy").

k9uwa

k9uwa 9 minutos hace

I would be totally ELATED if TGD showed up with just ONE of them. George read your mail
John k9uwa

Ishares S&P ASX 20

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones